0001104659-20-072556.txt : 20200611
0001104659-20-072556.hdr.sgml : 20200611
20200611210040
ACCESSION NUMBER: 0001104659-20-072556
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200609
FILED AS OF DATE: 20200611
DATE AS OF CHANGE: 20200611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alleva Lawrence M
CENTRAL INDEX KEY: 0001553053
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37368
FILM NUMBER: 20958635
MAIL ADDRESS:
STREET 1: 1000 WINTER STREET
STREET 2: SUITE 3300
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adaptimmune Therapeutics PLC
CENTRAL INDEX KEY: 0001621227
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 JUBILEE AVENUE
STREET 2: MILTON PARK
CITY: ABINGDON, OXFORDSHIRE
STATE: X0
ZIP: OX14 4RX
BUSINESS PHONE: 44 1235 430000
MAIL ADDRESS:
STREET 1: 60 JUBILEE AVENUE
STREET 2: MILTON PARK
CITY: ABINGDON, OXFORDSHIRE
STATE: X0
ZIP: OX14 4RX
FORMER COMPANY:
FORMER CONFORMED NAME: Adaptimmune Ltd
DATE OF NAME CHANGE: 20141001
4
1
a4.xml
4
X0306
4
2020-06-09
0
0001621227
Adaptimmune Therapeutics PLC
ADAP
0001553053
Alleva Lawrence M
C/O ADAPTIMMUNE THERAPEUTICS PLC,
60 JUBILEE AVE, MILTON PARK
ABINGDON
X0
OX14 4RX
UNITED KINGDOM
1
0
0
0
Ordinary Shares with a nominal value of GBP0.001 per share
2020-06-09
4
P
0
12900
1.89
A
12900
I
Held by Trust
Ordinary Shares with a nominal value of GBP0.001 per share
47280
I
Held by Trust
Ordinary Shares with a nominal value of GBP0.001 per share
70584
D
The ordinary shares whose purchase is reported on this line are represented by American Depositary Shares ("ADS") and are held in the form of ADSs by the Lawrence M. Alleva Revocable Trust. Each ADS represents six ordinary shares of Adaptimmune Therapeutics plc.
The 12,900 ordinary shares reported in Column 4 and Column 5 are represented by 2,150 ADSs.
The price reported in Column 4 of $1.89 per ordinary share is derived from the purchase price paid on June 9, 2020 of $11.354 per ADS divided by six.
The 47,280 ordinary shares reported in Column 5 are represented by 7,880 ADSs. These shares are held in the form of ADSs by the Lawrence M. Alleva Revocable Trust.
The 70,584 ordinary shares reported in Column 5 are represented by 11,764 ADSs. These shares are held in the form of ADSs by Mr. Alleva.
/s/ Lawrence M. Alleva
2020-06-11